SK6342000A3 - 6,11-bridged erythromycin derivatives - Google Patents

6,11-bridged erythromycin derivatives Download PDF

Info

Publication number
SK6342000A3
SK6342000A3 SK634-2000A SK6342000A SK6342000A3 SK 6342000 A3 SK6342000 A3 SK 6342000A3 SK 6342000 A SK6342000 A SK 6342000A SK 6342000 A3 SK6342000 A3 SK 6342000A3
Authority
SK
Slovakia
Prior art keywords
compound
formula
heteroarylene
arylene
group
Prior art date
Application number
SK634-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Yat Sun Or
George Griesgraber
Leping Li
Daniel T Chu
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of SK6342000A3 publication Critical patent/SK6342000A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SK634-2000A 1997-10-29 1998-10-29 6,11-bridged erythromycin derivatives SK6342000A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96040097A 1997-10-29 1997-10-29
US15826998A 1998-09-22 1998-09-22
PCT/US1998/022941 WO1999021864A1 (en) 1997-10-29 1998-10-29 6,11-bridged erythromycin derivatives

Publications (1)

Publication Number Publication Date
SK6342000A3 true SK6342000A3 (en) 2000-09-12

Family

ID=26854886

Family Applications (1)

Application Number Title Priority Date Filing Date
SK634-2000A SK6342000A3 (en) 1997-10-29 1998-10-29 6,11-bridged erythromycin derivatives

Country Status (23)

Country Link
EP (1) EP1027361B1 (tr)
JP (1) JP2001521038A (tr)
KR (1) KR20010031591A (tr)
CN (1) CN1278266A (tr)
AR (1) AR015986A1 (tr)
AT (1) ATE239750T1 (tr)
AU (1) AU1286799A (tr)
BG (1) BG104425A (tr)
BR (1) BR9813317A (tr)
CA (1) CA2307828A1 (tr)
CO (1) CO4990972A1 (tr)
DE (1) DE69814441T2 (tr)
DK (1) DK1027361T3 (tr)
ES (1) ES2198766T3 (tr)
HU (1) HUP0004323A2 (tr)
IL (1) IL134996A0 (tr)
NO (1) NO20002099L (tr)
PL (1) PL340253A1 (tr)
PT (1) PT1027361E (tr)
SK (1) SK6342000A3 (tr)
TR (1) TR200001140T2 (tr)
TW (1) TW486485B (tr)
WO (1) WO1999021864A1 (tr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6437106B1 (en) * 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
US6472372B1 (en) * 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
US6713455B2 (en) 2001-09-17 2004-03-30 Ortho-Mcneil Pharmaceutical, Inc. 6-O-carbamate-11,12-lacto-ketolide antimicrobials
CA2469304A1 (en) 2001-12-05 2003-06-19 Ortho-Mcneil Pharmaceutical, Inc. 6-o acyl ketolide antibacterials
US6753318B1 (en) 2002-07-25 2004-06-22 Enanta Pharmaceuticals, Inc. 6,11-4-carbon bridged erythromycin derivatives
US6841664B2 (en) * 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
JP2005536465A (ja) 2002-05-13 2005-12-02 エナンタ ファーマシューティカルズ インコーポレイテッド ６，１１二環式エリスロマイシン誘導体
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
AU2003229037B8 (en) * 2002-05-13 2009-07-02 Enanta Pharmaceuticals, Inc. 6,11 bicyclic erythromycin derivatives
US7273853B2 (en) 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US6645941B1 (en) * 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
US7414030B2 (en) 2004-01-07 2008-08-19 Enanta Pharmaceuticals, Inc. 6-11 Bicyclic erythromycin derivatives
WO2005070113A2 (en) 2004-01-09 2005-08-04 Enanta Pharmaceuticals, Inc. 9n-substituted 6-11 bicyclic erythromycin derivatives
WO2005080408A1 (en) * 2004-01-23 2005-09-01 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US7384921B2 (en) 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US7384922B2 (en) 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US7589067B2 (en) 2005-10-12 2009-09-15 Enanta Pharmaceuticals, Inc. 6, 11-bridged tricyclic macrolides
US8273720B2 (en) 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
US11673910B2 (en) 2017-04-28 2023-06-13 Zikani Therapeutics, Inc. Macrolides with modified desosamine sugars and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0876388T3 (da) * 1995-11-08 2004-06-07 Abbott Lab Tricykliske erythromycinderivater

Also Published As

Publication number Publication date
NO20002099L (no) 2000-06-29
JP2001521038A (ja) 2001-11-06
PT1027361E (pt) 2003-09-30
TR200001140T2 (tr) 2001-05-21
EP1027361A1 (en) 2000-08-16
CA2307828A1 (en) 1999-05-06
IL134996A0 (en) 2001-05-20
EP1027361B1 (en) 2003-05-07
BG104425A (bg) 2001-01-31
AR015986A1 (es) 2001-05-30
DE69814441D1 (de) 2003-06-12
DK1027361T3 (da) 2003-08-25
WO1999021864A1 (en) 1999-05-06
NO20002099D0 (no) 2000-04-25
ATE239750T1 (de) 2003-05-15
ES2198766T3 (es) 2004-02-01
AU1286799A (en) 1999-05-17
BR9813317A (pt) 2000-08-22
HUP0004323A2 (hu) 2001-02-28
TW486485B (en) 2002-05-11
PL340253A1 (en) 2001-01-29
KR20010031591A (ko) 2001-04-16
DE69814441T2 (de) 2004-04-08
CN1278266A (zh) 2000-12-27
CO4990972A1 (es) 2000-12-26

Similar Documents

Publication Publication Date Title
US6046171A (en) 6,11-bridged erythromycin derivatives
SK6342000A3 (en) 6,11-bridged erythromycin derivatives
SK285535B6 (sk) 6-O-Substituované ketolidy s antibakteriálnou aktivitou, farmaceutická kompozícia s ich obsahom, ich použitie a spôsob ich prípravy
CZ303573B6 (cs) 6-O-substituovaný ketolidový derivát erythromycinu, jeho použití, farmaceutická kompozice ho obsahující a zpusob jeho výroby
AU737310B2 (en) 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
SK3032000A3 (en) 6,9-bridged erythromycin derivatives
SK286397B6 (sk) 2-Halogén-6-O-substituované ketolidové deriváty, ich použitie, spôsob ich prípravy a farmaceutické kompozície s ich obsahom
US6420535B1 (en) 6-O-carbamate ketolide derivatives
US6034069A (en) 3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity
US6946446B2 (en) Anti-infective agents useful against multidrug-resistant strains of bacteria
CA2301642A1 (en) 3-descladinose 6-o-substituded erythromycin derivatives
EP1181300B1 (en) 6-o-carbamate ketolide derivatives
JP2003501439A5 (tr)
EP1259923B1 (en) Anti-infective agents useful against mulitidrug-resistant strains of bacteria
CZ20001394A3 (cs) Erythromycinové deriváty s 6,11-přemostěním
AU714176B2 (en) 3-deoxy-3-descladinose derivatives of erythromycins A and B
SK160299A3 (en) Multicyclic erythromycin derivatives
MXPA00004227A (en) 6,11-bridged erythromycin derivatives
MXPA00002216A (en) 3-descladinose 6-o-substituded erythromycin derivatives
CZ2000811A3 (cs) 6,9-můstkové erythromycinové deriváty a způsob jejich přípravy
CZ20001045A3 (cs) 3-N-módilikováné 6-O-substituované ketolidové deriváty erytromycinu
CZ407399A3 (cs) Multicyklické deriváty erythromycinu